207 related articles for article (PubMed ID: 32630529)
21. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
Luk KC; Hyde EG; Trojanowski JQ; Lee VM
Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
[TBL] [Abstract][Full Text] [Related]
22. In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation.
Jafaripour SS; Gharaghani S; Nazarshodeh E; Haider S; Saboury AA
Comput Biol Chem; 2020 Oct; 88():107308. PubMed ID: 32650066
[TBL] [Abstract][Full Text] [Related]
23. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
[TBL] [Abstract][Full Text] [Related]
24. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
Chaari A; Eliezer D; Ladjimi M
Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
[TBL] [Abstract][Full Text] [Related]
25. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
26. Inhibition-mediated changes in prolyl oligopeptidase dynamics possibly related to α-synuclein aggregation.
Walczewska-Szewc K; Rydzewski J; Lewkowicz A
Phys Chem Chem Phys; 2022 Feb; 24(7):4366-4373. PubMed ID: 35112120
[TBL] [Abstract][Full Text] [Related]
27. Anti-oligomerization sheet molecules: Design, synthesis and evaluation of inhibitory activities against α-synuclein aggregation.
Liu H; Chen L; Zhou F; Zhang YX; Xu J; Xu M; Bai SP
Bioorg Med Chem; 2019 Jul; 27(14):3089-3096. PubMed ID: 31196755
[TBL] [Abstract][Full Text] [Related]
28. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
Zaidi FK; Deep S
Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
[TBL] [Abstract][Full Text] [Related]
29. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates.
Tanaka G; Yamanaka T; Furukawa Y; Kajimura N; Mitsuoka K; Nukina N
Biochem Biophys Res Commun; 2019 Jan; 508(3):729-734. PubMed ID: 30528390
[TBL] [Abstract][Full Text] [Related]
31. Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.
Savolainen MH; Yan X; Myöhänen TT; Huttunen HJ
J Biol Chem; 2015 Feb; 290(8):5117-5126. PubMed ID: 25555914
[TBL] [Abstract][Full Text] [Related]
32. Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model: This is the reply to a comment "Alpha-synuclein oligomerization and aggregation: A model will always be a model" on the original article "Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get". The articles are accompanied by a Preface "How good are cellular models?".
Lashuel HA
J Neurochem; 2021 May; 157(4):891-898. PubMed ID: 33336386
[TBL] [Abstract][Full Text] [Related]
33. CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation.
Elsholz L; Wasser Y; Ziegler P; Habib P; Voigt A
Cells; 2021 Oct; 10(11):. PubMed ID: 34831053
[TBL] [Abstract][Full Text] [Related]
34. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
[TBL] [Abstract][Full Text] [Related]
35. The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity.
Szeltner Z; Alshafee I; Juhász T; Parvari R; Polgár L
Cell Mol Life Sci; 2005 Oct; 62(19-20):2376-81. PubMed ID: 16143824
[TBL] [Abstract][Full Text] [Related]
36. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
Teng Y; Zhao J; Ding L; Ding Y; Zhou P
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
[TBL] [Abstract][Full Text] [Related]
37. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
[TBL] [Abstract][Full Text] [Related]
38. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies.
Marvian AT; Koss DJ; Aliakbari F; Morshedi D; Outeiro TF
J Neurochem; 2019 Sep; 150(5):535-565. PubMed ID: 31004503
[TBL] [Abstract][Full Text] [Related]
39. Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein.
Tanaka G; Yamanaka T; Furukawa Y; Kajimura N; Mitsuoka K; Nukina N
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1410-1420. PubMed ID: 30790619
[TBL] [Abstract][Full Text] [Related]
40. Defining an amyloid link Between Parkinson's disease and melanoma.
Dean DN; Lee JC
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22671-22673. PubMed ID: 32868414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
